Robert Bahnson

EFFICACY AND SAFETY OF VALRUBICIN FOR THE TREATMENT OF BACILLUS CALMETTE-GUERIN REFRACTORY CARCINOMA IN SITU OF THE BLADDER

Gary D. Steinberg, Robert Bahnson, Stanley A. Brosman et al. · The Journal of Urology · 2000 · 340 citations

Medicine, Oncology, Urology +6

Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer

Jennifer L. Osborn, Gary G. Schwartz, David C. Smith et al. · Urologic Oncology Seminars and Original Investigations · 1995 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17

Preliminary Imaging Results Using In-111 Labeled CYT-356 (Prostascintst) in the Detection of Recurrent Prostate Cancer

D. Bruce Sodee, Ridgely Conant, M Chalfant et al. · Clinical Nuclear Medicine · 1996 · 62 citations

Medicine, Nuclear Medicine, Radiology +17

NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network.

Howard I. Scher, Robert Bahnson, Samuel M. Cohen et al. · PubMed · 1998 · 53 citations

Medicine, Oncology, Surgery +16

Pilot study of the tolerability and toxicity of intravesical valrubicin immediately after transurethral resection of superficial bladder cancer

Anthony L. Patterson, Richard E. Greenberg, Lamar Weems et al. · Urology · 2000 · 33 citations

Medicine, Surgery, Urology +15